相关实验视频
Updated: Jan 12, 2026

07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
86.2K
鉴定缺氧相关基因作为性结肠炎的潜在诊断生物标志物
Yuhan Ren1, Guoshu Cao1, Gang Wei1
1Department of Gastroenterology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, PR China.
概括
与缺氧相关的基因 (HRGs) 显示出作为性结肠炎 (UC) 的诊断标记物的希望. 在临床样本中,九个已识别的枢纽基因表现出显著的诊断能力,这表明它们在UC发育中的作用.
科学领域:
- 基因组学和生物信息学
- 分子生物学分子生物学
- 胃肠病学 胃肠病学
背景情况:
- 在全球范围内,性结肠炎 (UC) 的发病率正在增加.
- 新的诊断方法对于管理UC至关重要.
- 与缺氧相关的基因 (HRG) 正在研究它们的潜在作用.
研究的目的:
- 识别和验证缺氧相关基因 (HRGs) 作为性结肠炎 (UC) 的潜在诊断标记物.
- 在UC患者中探索差异表达HRG的诊断价值.
主要方法:
- 使用了来自GEO数据库的UC数据集 (GSE87466,GSE92415) 的生物信息学分析.
- 使用PPI网络识别差异表达HRG (DEHRG) 和枢纽基因.
- 在临床UC样本上通过ROC曲线和qRT-PCR验证诊断潜力.
主要成果:
- 确定了28个DEHRG,其中9个枢纽基因在UC中显示出显著的诊断潜力 (AUC>0.7).
- 在已识别的枢纽基因中,PPARGC1A表现出最高的诊断价值.
- 与对照组相比,UC患者的9个枢纽基因表达显著改变,与生物信息学预测一致.
结论:
- 与缺氧相关的基因 (HRG) 是UC病原和进展的组成部分.
- 这九个已识别的枢纽基因代表了性结肠炎 (UC) 的有前途的诊断生物标志物.
- 对这些HRG的进一步研究可能会导致改善UC诊断.
更多相关视频
相关概念视频
Serum Laboratory Studies, Stool Test, Breath Test
738
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
738
Inflammatory Bowel Disease I: Ulcerative Colitis
880
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
880
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
622
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
622
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
522
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
522

